A AstraZeneca’s vaccine against Covid-19 will no longer be sold in the European Union from Tuesday. The decision came after the European Commission (EC) withdrew marketing authorization at the end of March at the request of the British pharmaceutical company itself.
“At the request of the owner, the authorization to market the vaccine against Covid-19 Vaxzevria, granted on January 29, 2021, is withdrawn”, states a document dated March 27 of this year from the EC.
According to 20 minutes, AstraZeneca’s request is related to the lack of demand for the drug and the excess of vaccines available on the market. “As several updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has led to a decrease in demand for Vaxzervria, which is no longer being manufactured or supplied,” the company highlighted in a statement.
After Brussels’ decision, AstraZeneca recalled the role of the vaccine in the fight against coronavirus. “According to independent estimates, more than 6.5 million lives were saved and more than 3 billion doses were delivered worldwide in the first year of use alone.”
Read Also: Profit of pharmaceutical company AstraZeneca rises 20% to 2,031 million by March
Download our free App.
Eighth consecutive year Consumer Choice for Online Press and elected product of the year 2024.
* Study by e Netsonda, Nov. and ten. 2023 product of the year – pt.com
Download our free App.
Eighth consecutive year Consumer Choice for Online Press and elected product of the year 2024.
* Study by e Netsonda, Nov. and ten. 2023 product of the year – pt.com
Tags: AstraZeneca vaccine Covid19 longer sold
